Literature DB >> 11757036

Proteomic analysis of normal and malignant prostate tissue to identify novel proteins lost in cancer.

Katie L Meehan1, John W Holland, Hugh J S Dawkins.   

Abstract

BACKGROUND: Alterations of important protein pathways, including loss of prostate secretory granules, and disruption of the prostatic secretory pathway have been identified as early events in malignancy. In this study, proteomics was used to map the differences in protein expression between normal and malignant prostate tissues and to identify and analyze differentially expressed proteins in human prostate tissue with particular regard to the proteins lost in malignancy.
METHODS: Small quantities of normal and malignant prostate tissue were taken fresh from 34 radical prostatectomy cases. After histological examination, proteins were solubilized from selected tissues and separated using two-dimensional electrophoresis. Using image analysis, the proteome of normal and malignant tissues were mapped and differentially expressed proteins (present in normal and absent in malignant tissue) were identified and subsequently analyzed using peptide mass finger printing and N-terminal sequencing. Western blotting and immunohistochemistry were performed to examine expression profiles and tissue localization of candidate proteins.
RESULTS: Comparison of protein maps of normal and malignant prostate were used to identify 20 proteins which were lost in malignant transformation, including prostate specific antigen (PSA), alpha-1 antichymotrypsin (ACT), haptoglobin, and lactoylglutathione lyase. Three of the 20 had not previously been reported in human prostate tissue (Ubiquitin-like NEDD8, calponin, and a follistatin-related protein). Western blotting confirmed differences in the expression profiles of NEDD8 and calponin, and immunohistochemistry demonstrated differences in the cellular localization of these two proteins in normal and malignant prostate glands.
CONCLUSIONS: The expression of NEDD8, calponin, and the follistatin-related protein in normal prostate tissues is a novel finding and the role of these important functional proteins in normal prostate and their loss or reduced expression in prostate malignancy warrants further investigations. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11757036     DOI: 10.1002/pros.10032

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  22 in total

Review 1.  Current perspectives in cancer proteomics.

Authors:  Miriam V Dwek; Sarah L Rawlings
Journal:  Mol Biotechnol       Date:  2002-10       Impact factor: 2.695

2.  Selenium-responsive proteins in the sera of selenium-enriched yeast-supplemented healthy African American and Caucasian men.

Authors:  Raghu Sinha; Indu Sinha; Nicole Facompre; Stephen Russell; Richard I Somiari; John P Richie; Karam El-Bayoumy
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-07-19       Impact factor: 4.254

3.  Proteomic analyses to identify novel therapeutic targets for the treatment of advanced prostate cancer.

Authors:  Barbara Comuzzi; Marianne D Sadar
Journal:  Cellscience       Date:  2006-07-27

4.  Gleason score and pretreatment prostate-specific antigen in survival among patients with stage D2 prostate cancer.

Authors:  William D Figg; Michael E Franks; David Venzon; Paul Duray; Michael C Cox; W Marston Linehan; W Van Bingham; James A Eastham; Eddie Reed; Oliver Sartor
Journal:  World J Urol       Date:  2004-12-08       Impact factor: 4.226

5.  3-D photoacoustic and pulse echo imaging of prostate tumor progression in the mouse window chamber.

Authors:  Daniel R Bauer; Ragnar Olafsson; Leonardo G Montilla; Russell S Witte
Journal:  J Biomed Opt       Date:  2011-02       Impact factor: 3.170

6.  Hox B4 as potential marker of non-differentiated cells in human cervical cancer cells.

Authors:  Ana P Barba-de la Rosa; Erika Briones-Cerecero; Ofelia Lugo-Melchor; Antonio De León-Rodríguez; Leticia Santos; Julio Castelo-Ruelas; Alejandra Valdivia; Patricia Piña; Alicia Chagolla-López; Daniel Hernandez-Cueto; Alejandra Mantilla; Minerva Lazos-Ochoa; Beatriz Gonzalez-Yebra; Mauricio Salcedo
Journal:  J Cancer Res Clin Oncol       Date:  2011-11-27       Impact factor: 4.553

7.  Hypoxia-inducible factor α subunit stabilization by NEDD8 conjugation is reactive oxygen species-dependent.

Authors:  Ji-Hye Ryu; Shan-Hua Li; Hyoung-Sook Park; Jong-Wan Park; Byunglan Lee; Yang-Sook Chun
Journal:  J Biol Chem       Date:  2010-12-30       Impact factor: 5.157

8.  Peroxiredoxin 2: a potential biomarker for early diagnosis of hepatitis B virus related liver fibrosis identified by proteomic analysis of the plasma.

Authors:  Ye Lu; Jie Liu; Chengzhao Lin; Haijian Wang; Ying Jiang; Jiyao Wang; Pengyuan Yang; Fuchu He
Journal:  BMC Gastroenterol       Date:  2010-10-13       Impact factor: 3.067

Review 9.  Calponin isoforms CNN1, CNN2 and CNN3: Regulators for actin cytoskeleton functions in smooth muscle and non-muscle cells.

Authors:  Rong Liu; J-P Jin
Journal:  Gene       Date:  2016-03-10       Impact factor: 3.688

10.  Protein expression analysis of inflammation-related colon carcinogenesis.

Authors:  Yumiko Yasui; Takuji Tanaka
Journal:  J Carcinog       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.